P
Prothena Corp D
D
PRTA
5.08500
USD
0.02
(0.30%)
مغلق
حجم التداول
25,129
الربح لكل سهم
-3
العائد الربحي
-
P/E
-2
حجم السوق
273,710,203
الأخبار المقالات
العنوان: Prothena Corp
القطاع: Healthcare
الصناعة: Biotechnology
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.